Comments

Gilead Sciences Analyst Ratings

GILDNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$119.60

-0.18-0.15%

Last update: Dec 16, 10:54 AM

The dividend Ex-Date was 1 day ago

Overview News Earnings Options Guidance Dividends

Analyst Ratings

Insider Trades Short Interest Government Trades Stock Report

Consensus Rating¹

Outperform

Highest Price Target¹

$151.00

Lowest Price Target¹

$69.00

Consensus Price Target¹

$116.83

Gilead Sciences Analyst Ratings and Price Targets | NASDAQ:GILD | Benzinga

Gilead Sciences Inc has a consensus price target of $116.83 based on the ratings of 30 analysts. The high is $151 issued by Morgan Stanley on December 12, 2025. The low is $69 issued by HSBC on April 24, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and Truist Securities on December 12, 2025, December 10, 2025, and November 24, 2025, respectively. With an average price target of $147 between Morgan Stanley, Wells Fargo, and Truist Securities, there's an implied 22.91% upside for Gilead Sciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Morgan Stanley

Wells Fargo

Truist Securities

Needham

Scotiabank

¹calculated from analyst ratings

Analyst Ratings for Gilead Sciences

					Get Alert
Dec 12, 2025	26.25%	Matthew HarrisonMorgan Stanley 61%	147 151	Previous Overweight Current Overweight	Get Alert
Dec 10, 2025	25.42%	Mohit BansalWells Fargo 68%	145 150	Previous Overweight Current Overweight	Get Alert
Nov 24, 2025	17.06%	Gregory RenzaTruist Securities 69%	140 145	Previous Current Buy	Get Alert
Nov 13, 2025	17.06%	Joseph StringerNeedham 78%	133 140	Previous Buy Current Buy	Get Alert
Nov 13, 2025	17.06%	Louis ChenScotiabank 19%	140	Previous Initiates Current Sector Outperform	Get Alert
Nov 3, 2025	21.24%	Asthika GoonewardeneTruist Securities 48%	127 145	Previous Buy Current Buy	Get Alert
Oct 31, 2025	21.24%	Mohit BansalWells Fargo 68%	140 145	Previous Overweight Current Overweight	Get Alert
Oct 31, 2025	25.42%	Chris SchottJP Morgan 65%	145 150	Previous Overweight Current Overweight	Get Alert
Oct 31, 2025	-12.21%	Brian AbrahamsRBC Capital 57%	100 105	Previous Sector Perform Current Sector Perform	Get Alert
Oct 31, 2025	12.88%	Carter GouldCantor Fitzgerald 63%	135 135	Previous Overweight Current Overweight	Get Alert
Oct 31, 2025	11.2%	Joseph StringerNeedham 78%	133 133	Previous Buy Current Buy	Get Alert
Oct 23, 2025	4.52%	Tyler Van BurenTD Cowen 52%	115 125	Previous Buy Current Buy	Get Alert
Oct 8, 2025	12.88%	Geoff MeachamCitigroup 73%	125 135	Previous Buy Current Buy	Get Alert
Sep 16, 2025	21.24%	Chris SchottJP Morgan 65%	135 145	Previous Overweight Current Overweight	Get Alert
Aug 8, 2025	-18.06%	Brian AbrahamsRBC Capital 57%	96 98	Previous Sector Perform Current Sector Perform	Get Alert
Aug 8, 2025	-6.35%	Colin BristowUBS 44%	108 112	Previous Neutral Current Neutral	Get Alert
Aug 8, 2025	6.19%	Asthika GoonewardeneTruist Securities 48%	108 127	Previous Hold Current Buy	Get Alert
Jul 25, 2025	11.2%	Joseph StringerNeedham 78%	133	Previous Hold Current Buy	Get Alert
May 21, 2025	—	Joseph StringerNeedham 78%	—	Previous Hold Current Hold	Get Alert
May 5, 2025	-2.17%	Salim SyedMizuho 50%	100 117	Previous Outperform Current Outperform	Get Alert
Apr 25, 2025	4.52%	Hartaj SinghOppenheimer 48%	125 132	Previous Outperform Current Outperform	Get Alert
Apr 25, 2025	12.88%	Matthew HarrisonMorgan Stanley 61%	130 135	Previous Overweight Current Overweight	Get Alert
Apr 25, 2025	—	Joseph StringerNeedham 78%	—	Previous Hold Current Hold	Get Alert
Apr 22, 2025	4.52%	Carter GouldCantor Fitzgerald 63%	125	Previous Current Overweight	Get Alert
Apr 17, 2025	0.33%	Evan SeigermanBMO Capital 66%	115 120	Previous Outperform Current Outperform	Get Alert
Mar 27, 2025	8.7%	Chris SchottJP Morgan 65%	120 130	Previous Overweight Current Overweight	Get Alert
Mar 11, 2025	8.7%	Matthew HarrisonMorgan Stanley 61%	123 130	Previous Overweight Current Overweight	Get Alert
Mar 5, 2025	5.35%	Tim AndersonB of A Securities 63%	116 126	Previous Buy Current Buy	Get Alert
Mar 5, 2025	17.06%	Mohit BansalWells Fargo 68%	120 140	Previous Overweight Current Overweight	Get Alert
Mar 4, 2025	10.37%	Hartaj SinghOppenheimer 48%	115 132	Previous Outperform Current Outperform	Get Alert
Feb 18, 2025	0.33%	James ShinDeutsche Bank 62%	80 120	Previous Hold Current Buy	Get Alert
Feb 13, 2025	-3.01%	Tim AndersonB of A Securities 63%	109 116	Previous Buy Current Buy	Get Alert
Feb 12, 2025	0.33%	Chris SchottJP Morgan 65%	115 120	Previous Overweight Current Overweight	Get Alert
Feb 12, 2025	-16.39%	Brian SkorneyBaird 60%	95 100	Previous Neutral Current Neutral	Get Alert
Feb 12, 2025	-24.75%	Brian AbrahamsRBC Capital 57%	84 90	Previous Sector Perform Current Sector Perform	Get Alert
Feb 12, 2025	-19.73%	Salveen RichterGoldman Sachs 57%	85 96	Previous Neutral Current Neutral	Get Alert
Feb 12, 2025	-3.85%	Evan SeigermanBMO Capital 66%	110 115	Previous Outperform Current Outperform	Get Alert
Feb 12, 2025	0.33%	Mohit BansalWells Fargo 68%	105 120	Previous Overweight Current Overweight	Get Alert
Feb 12, 2025	-8.03%	Joseph CatanzaroPiper Sandler 59%	105 110	Previous Overweight Current Overweight	Get Alert
Feb 12, 2025	2.84%	Matthew HarrisonMorgan Stanley 61%	113 123	Previous Overweight Current Overweight	Get Alert
Feb 12, 2025	—	Joseph StringerNeedham 78%	—	Previous Hold Current Hold	Get Alert
Feb 3, 2025	-29.77%	Brian AbrahamsRBC Capital 57%	84 84	Previous Sector Perform Current Sector Perform	Get Alert
Jan 29, 2025	-8.03%	Evan SeigermanBMO Capital 66%	102 110	Previous Outperform Current Outperform	Get Alert
Jan 29, 2025	-3.85%	Chris SchottJP Morgan 65%	105 115	Previous Overweight Current Overweight	Get Alert
Jan 10, 2025	-5.52%	Matthew HarrisonMorgan Stanley 61%	87 113	Previous Equal-Weight Current Overweight	Get Alert
Dec 11, 2024	-33.11%	Olivia BrayerCantor Fitzgerald 59%	80 80	Previous Neutral Current Neutral	Get Alert
Dec 11, 2024	-29.77%	Brian AbrahamsRBC Capital 57%	84 84	Previous Sector Perform Current Sector Perform	Get Alert
Dec 10, 2024	-3.85%	Matthew BieglerOppenheimer 62%	105 115	Previous Outperform Current Outperform	Get Alert
Dec 10, 2024	-8.86%	Tim AndersonB of A Securities 63%	109	Previous Current Buy	Get Alert
Nov 21, 2024	-19.73%	Colin BristowUBS 44%	70 96	Previous Neutral Current Neutral	Get Alert
Nov 21, 2024	-16.39%	Salim SyedMizuho 50%	90 100	Previous Outperform Current Outperform	Get Alert
Nov 18, 2024	-29.77%	Brian AbrahamsRBC Capital 57%	81 84	Previous Sector Perform Current Sector Perform	Get Alert
Nov 15, 2024	-8.03%	Alexandria HammondWolfe Research 62%	110	Previous Initiates Current Outperform	Get Alert
Nov 14, 2024	4.52%	Geoff MeachamCitigroup 73%	125	Previous Initiates Current Buy	Get Alert
Nov 8, 2024	-27.26%	Matthew HarrisonMorgan Stanley 61%	84 87	Previous Equal-Weight Current Equal-Weight	Get Alert
Nov 8, 2024	—	Jason McCarthyMaxim Group 45%	—	Previous Buy Current Hold	Get Alert
Nov 8, 2024	-18.9%	Asthika GoonewardeneTruist Securities 48%	83 97	Previous Hold Current Hold	Get Alert
Nov 7, 2024	-12.21%	Hartaj SinghOppenheimer 48%	95 105	Previous Outperform Current Outperform	Get Alert
Nov 7, 2024	-14.72%	Evan SeigermanBMO Capital 66%	94 102	Previous Outperform Current Outperform	Get Alert
Nov 7, 2024	-20.57%	Brian SkorneyBaird 60%	80 95	Previous Neutral Current Neutral	Get Alert
Nov 7, 2024	-12.21%	Chris SchottJP Morgan 65%	100 105	Previous Overweight Current Overweight	Get Alert
Nov 7, 2024	-32.27%	Brian AbrahamsRBC Capital 57%	75 81	Previous Sector Perform Current Sector Perform	Get Alert
Nov 7, 2024	-29.77%	Salveen RichterGoldman Sachs 57%	74 84	Previous Neutral Current Neutral	Get Alert
Nov 7, 2024	-33.11%	Olivia BrayerCantor Fitzgerald 59%	70 80	Previous Neutral Current Neutral	Get Alert
Nov 7, 2024	-12.21%	Mohit BansalWells Fargo 68%	100 105	Previous Overweight Current Overweight	Get Alert
Nov 7, 2024	-20.57%	Carter GouldBarclays 63%	84 95	Previous Equal-Weight Current Equal-Weight	Get Alert
Nov 7, 2024	-12.21%	Joseph CatanzaroPiper Sandler 59%	95 105	Previous Overweight Current Overweight	Get Alert
Nov 7, 2024	—	Joseph StringerNeedham 78%	—	Previous Current Hold	Get Alert
Oct 29, 2024	-37.29%	Brian AbrahamsRBC Capital 57%	75 75	Previous Sector Perform Current Sector Perform	Get Alert
Oct 21, 2024	-19.73%	Andrew BerensLeerink Partners 51%	74 96	Previous Market Perform Current Outperform	Get Alert
Oct 17, 2024	-21.4%	Evan SeigermanBMO Capital 66%	85 94	Previous Outperform Current Outperform	Get Alert
Oct 17, 2024	-12.21%	Aaron GalBernstein 53%	105	Previous Initiates Current Outperform	Get Alert
Oct 9, 2024	-16.39%	Chris SchottJP Morgan 65%	95 100	Previous Overweight Current Overweight	Get Alert
Oct 7, 2024	-29.77%	Carter GouldBarclays 63%	76 84	Previous Equal-Weight Current Equal-Weight	Get Alert
Oct 7, 2024	-16.39%	Mohit BansalWells Fargo 68%	78 100	Previous Equal-Weight Current Overweight	Get Alert
Oct 4, 2024	-37.29%	Brian AbrahamsRBC Capital 57%	74 75	Previous Sector Perform Current Sector Perform	Get Alert
Sep 16, 2024	-41.47%	Olivia BrayerCantor Fitzgerald 59%	70 70	Previous Neutral Current Neutral	Get Alert
Sep 11, 2024	-20.57%	Joseph CatanzaroPiper Sandler 59%	95 95	Previous Overweight Current Overweight	Get Alert
Sep 9, 2024	-41.47%	Olivia BrayerCantor Fitzgerald 59%	70 70	Previous Neutral Current Neutral	Get Alert
Sep 4, 2024	-38.13%	Brian AbrahamsRBC Capital 57%	72 74	Previous Sector Perform Current Sector Perform	Get Alert
Aug 15, 2024	-30.6%	Robyn KarnauskasTruist Securities 54%	82 83	Previous Hold Current Hold	Get Alert
Aug 15, 2024	—	Joseph StringerNeedham 78%	—	Previous Current Hold	Get Alert
Aug 9, 2024	-39.8%	Brian AbrahamsRBC Capital 57%	71 72	Previous Sector Perform Current Sector Perform	Get Alert
Aug 9, 2024	-41.47%	Olivia BrayerCantor Fitzgerald 59%	70 70	Previous Neutral Current Neutral	Get Alert
Aug 9, 2024	-28.93%	Evan SeigermanBMO Capital 66%	80 85	Previous Outperform Current Outperform	Get Alert
Jul 22, 2024	-41.47%	Olivia BrayerCantor Fitzgerald 59%	70 75	Previous Neutral Current Neutral	Get Alert
Jul 8, 2024	-22.24%	Steven SeedhouseRaymond James 57%	93	Previous Market Perform Current Outperform	Get Alert
Jul 1, 2024	-38.13%	Brian AbrahamsRBC Capital 57%	74 74	Previous Sector Perform Current Sector Perform	Get Alert
Jun 20, 2024	-33.11%	Brian SkorneyBaird 60%	80 80	Previous Neutral Current Neutral	Get Alert
Jun 14, 2024	-38.13%	Brian AbrahamsRBC Capital 57%	74 74	Previous Sector Perform Current Sector Perform	Get Alert
Apr 29, 2024	-36.45%	Carter GouldBarclays 63%	76 80	Previous Equal-Weight Current Equal-Weight	Get Alert
Apr 26, 2024	-28.93%	Tyler Van BurenTD Cowen 52%	85 90	Previous Buy Current Buy	Get Alert
Apr 26, 2024	-34.78%	Matthew HarrisonMorgan Stanley 61%	78 80	Previous Equal-Weight Current Equal-Weight	Get Alert
Apr 26, 2024	-38.13%	Brian AbrahamsRBC Capital 57%	74 76	Previous Sector Perform Current Sector Perform	Get Alert
Apr 26, 2024	—	Joseph StringerNeedham 78%	—	Previous Current Hold	Get Alert
Apr 24, 2024	-42.31%	Morten HerholdtHSBC 35%	69	Previous Reduce Current Hold	Get Alert
Apr 19, 2024	-12.21%	Hartaj SinghOppenheimer 48%	105 105	Previous Outperform Current Outperform	Get Alert
Apr 17, 2024	-37.29%	Colin BristowUBS 44%	75 81	Previous Neutral Current Neutral	Get Alert
Mar 4, 2024	-34.78%	Mohit BansalWells Fargo 68%	78 84	Previous Equal-Weight Current Equal-Weight	Get Alert
Feb 22, 2024	-24.75%	Salim SyedMizuho 50%	90 101	Previous Buy Current Buy	Get Alert

FAQ

What is the target price for Gilead Sciences (GILD) stock?

The latest price target for Gilead Sciences (NASDAQ:GILD) was reported by Morgan Stanley on December 12, 2025. The analyst firm set a price target for $151.00 expecting GILD to rise to within 12 months (a possible 26.25% upside). 45 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Gilead Sciences (GILD)?

The latest analyst rating for Gilead Sciences (NASDAQ:GILD) was provided by Morgan Stanley, and Gilead Sciences maintained their overweight rating.

When was the last upgrade for Gilead Sciences (GILD)?

The last upgrade for Gilead Sciences Inc happened on August 8, 2025 when Truist Securities raised their price target to $127. Truist Securities previously had a hold for Gilead Sciences Inc.

When was the last downgrade for Gilead Sciences (GILD)?

The last downgrade for Gilead Sciences Inc happened on November 8, 2024 when Maxim Group changed their price target from N/A to N/A for Gilead Sciences Inc.

When is the next analyst rating going to be posted or updated for Gilead Sciences (GILD)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gilead Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gilead Sciences was filed on December 12, 2025 so you should expect the next rating to be made available sometime around December 12, 2026.

Is the Analyst Rating Gilead Sciences (GILD) correct?

While ratings are subjective and will change, the latest Gilead Sciences (GILD) rating was a maintained with a price target of $147.00 to $151.00. The current price Gilead Sciences (GILD) is trading at is $119.60, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.